MYLAN 531 (Sulindac 200 mg)

Pill imprint MYLAN 531 has been identified as Sulindac 200 mg.

Sulindac is used in the treatment of pain; ankylosing spondylitis; osteoarthritis; gout, acute; juvenile rheumatoid arthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 531

Sulindac 200 mg MYLAN 531
Sulindac
Imprint:
MYLAN 531
Strength:
200 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0531
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0667 UDL Laboratories Inc
54569-4032 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)